GLP-1s and Appetite

‍
‍How GLP-1 Medications Impact Appetite and Metabolism
‍

For decades, weight loss advice has focused on willpower – eat less, move more, and hope for the best. But for many women, especially those with underlying metabolic conditions like PCOS or insulin resistance, that advice hasn’t worked.

Enter GLP-1 medications, like semaglutide (Wegovy) and tirzepatide (Mounjaro), a new generation of treatments that retrain your body’s hunger and metabolism from the inside out.

What Are GLP-1s?

GLP-1 (glucagon-like peptide-1) is a hormone your gut naturally produces in response to food. It helps:
‍

• Regulate blood sugar
  
• Signal fullness to your brain
  
• Slow digestion (so you feel full for longer)
  
  

GLP-1 medications mimic this hormone, helping your body do what it’s meant to do, but more effectively and consistently, especially if your natural regulation has been disrupted by stress, hormones, or insulin resistance.

 Appetite: Why You Feel More in Control

One of the most noticeable effects of GLP-1s is reduced appetite. This isn’t just about eating less, it’s about:
‍

• Feeling full after smaller portions
  
• Reduced cravings, especially for ultra-processed foods
  
• Less emotional or mindless eating
  

That’s because GLP-1s act directly on areas of the brain that control hunger, including the hypothalamus and brainstem. They also reduce levels of ghrelin, the hormone that tells you you're hungry.

For many SheMed members, this leads to a sense of freedom around food – less noise, fewer urges, and more space to build long-term habits.

Metabolism: Supporting Fat Loss From Within

GLP-1s don’t just reduce appetite – they also impact how your body burns and stores energy. Here’s how:
‍

• Lower insulin resistance: GLP-1s improve how your body uses insulin, which helps reduce fat storage, especially around the belly.
  
• Reduced inflammation: Chronic inflammation can interfere with weight loss. These meds help quiet that process.
  
• Improved fat oxidation: Your body becomes more efficient at breaking down fat for energy.
  
• More stable blood sugar: No more highs and crashes that lead to cravings and fatigue.
  
  

While GLP-1s don’t drastically “speed up” your metabolism, they help your metabolic system work the way it should, making weight loss more natural and sustainable, especially when paired with movement and protein-rich meals.

What the Research Says

• In clinical trials, people taking semaglutide lost an average of 15% of their body weight over 68 weeks, with significant improvements in blood pressure, cholesterol, and waist circumference  (NEJM, 2021 – Wilding et al.)
  
• Other studies show better glucose control and insulin sensitivity – particularly important for women with PCOS or prediabetes (Drucker, 2021 – Cell Metabolism)
  
• Unlike most weight loss drugs of the past, GLP-1s act on multiple systems at once, retraining appetite, mood, blood sugar, and fat metabolism.
  
  

Bottom Line: A Smarter Way to Support Weight Loss

GLP-1 medications aren’t just about weight – they’re about restoring metabolic balance, calming hunger, and making it easier to stick to healthy habits.

They won’t replace sleep, protein, hydration, or joyful movement – but they can finally help women who’ve struggled with appetite and metabolism stop fighting their biology and start feeling like themselves again.

‍

References

• Wilding, J. et al. (2021). Once-Weekly Semaglutide in Adults with Obesity. New England Journal of Medicine. PubMed
  
• Drucker, D. (2021). GLP-1 Physiology and Therapeutic Potential. Cell Metabolism. PubMed
  
• NHS – Weight Loss Medications

‍

‍